[Tubulointerstitiel nephritis and Crohn's disease, nephrotoxicity or extraintestinal manifestation of Crohn's disease? About a case]

Nephrol Ther. 2019 Mar;15(1):59-62. doi: 10.1016/j.nephro.2018.07.406. Epub 2018 Nov 29.
[Article in French]

Abstract

Extraintestinal manifestations in inflammatory bowel disease involve most frequently the joints, the skin, the eyes, the liver and the biliary tract. Renal involvement is rare, and manifested as nephrolithiasis, tubulointerstitial nephritis, glomerulonephritis and amyloidosis. In patients with inflammatory bowel disease, renal disease is most frequently due to treatment nephrotoxicity and rarely as a guenine extraintestinal manifestation of inflammatory bowel disease. We are reporting a case of tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease and we are explaining the diagnostic difficulty to distinguish this from drug-induced nephrotoxicity.

Keywords: Crohn's disease; Maladie de Crohn; Nephrotoxicity; Néphrite tubulo-interstitielle; Néphrotoxicité; Tubulointerstitial nephritis.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / administration & dosage
  • Adalimumab / adverse effects*
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects*
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Humans
  • Male
  • Nephritis, Interstitial / etiology*

Substances

  • Anti-Inflammatory Agents
  • Adalimumab